A new horizon of moyamoya disease and associated health risks explored through RNF213
The cerebrovascular disorder moyamoya disease (MMD) was first described in 1957 in Japan, and is typically considered to be an Asian-specific disease. However, it is globally recognized as one of the major causes of childhood stroke. Although several monogenic diseases are known to be complicated b...
Main Authors: | Koizumi, Akio, Kobayashi, Hatasu, Hitomi, Toshiaki, Harada, Kouji H., Habu, Toshiyuki, Youssefian, Shohab |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Japan
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771639/ |
Similar Items
-
RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients
by: Kobayashi, Hatasu, et al.
Published: (2016) -
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo
by: Kobayashi, Hatasu, et al.
Published: (2015) -
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
by: Liu, Wanyang, et al.
Published: (2011) -
Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population
by: Wu, Zhiyuan, et al.
Published: (2012) -
Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene
by: Fujimura, Miki, et al.
Published: (2014)